Non Interventional Study For Patients Treated With Somavert® (GPOS)

Pfizer

Status: Completed

Conditions: Acromegaly

Treatments: Other: Non Interventional Observation

Study type: Observational

Funder types: Industry

Identifiers

NCT00858143

A6291014

Details and patient eligibility

About

This open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study was performed in order to examine the efficacy and safety of Somavert® in treatment of subjects with acromegaly and its effects on acromegaly related co-morbidities.

Full description

Non probability samples

Enrollment: 311 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with diagnosed acromegaly who were already being treated with Somavert® or were to start treatment with Somavert® were included in the study.

Exclusion criteria

• Subjects treated with an investigational drug for treatment of acromegaly.
• Subjects with symptoms such visual field loss, cranial nerve palsies or intracranial hypertension, indicating need for surgery.
• Women who were pregnant or lactating.

Trial design

311 participants in 1 patient group

1

Treatment:

Other: Non Interventional Observation